Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program

Recruiting now · Not applicable

Conditions studied: Breast Neoplasm

In brief

The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.

Key facts

Study ID

NCT04652609

Run by

Universidad de Granada

People needed

25

Starts

2021-01-01

Expected to finish

2027-01-01

Last updated by the study team

2025-11-18

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• HER2+ breast cancer diagnosis
• On the waiting list to anticancer medical treatment (taxanes-based neoadjuvant chemotherapy)

You may not qualify if…

• Previous diagnosis of cancer
• Pregnant
• Cardiac pathology
• No symptoms or pathology that could be confused with neuropathy or related to diabetes
• No recommendation from oncologist for therapeutic exercise practice

Where it is running

• University of Granada — Granada, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.